Methotrexate Reagent and Controls

Pre-Solicitation Notice for 100% Small Business Set Aside acquisition of Methotrexate Assay Reagent, Calibration, and Control Kits.

The Regional Health Contracting Office - Central, JBSA, Fort Sam Houston, Texas, intends to purchase consumable Methotrexate Assay Reagent, Calibration, and Control Kits functional on automated clinical chemistry analyzer system in support of Brooke Army Medical Center, Fort Sam Houston, Texas. The reagent assay kits, calibration kits, and control kits, monitor the therapeutic levels of the anti-cancer drug methotrexate in serum and plasma specimens. The Methotrexate is a homogenous enzyme immunoassay intended for the quantitative determination of methotrexate in human serum or plasma on the automated clinical chemistry analyzers.

The NAICS code of this procurement is 325413 "In-Vitro Diagnostic Substance Manufacturing" and the size standard is 1,250 employees. This is a base plus four (4) option periods. The award will be awarded to the lowest price proposed and technically acceptable.

This notice is neither a request for quotes nor a solicitation of offers. The Sources Sought notice W81K00-18-Q-0175 was posted on FedBizOps (FBO) 10 August 2018 and closed on 15 August 2018. The acquisition strategy shall remain 100% small business. The reagents kits and supplies must have FDA certification, comply with CAP, and be compatible/functional on automated clinical chemistry analyzers.

.